Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Agilent Wins Trade Secret and Patent Infringement Litigation
Agilent Wins Trade Secret and Patent Infringement Litigation


Agilent Technologies Inc. (NYSE: A) today announced it has won a judgement in federal court for patent infringement and trade secret misappropriation against Shanghai-based J&X Technologies. The

AMN Healthcare Achieves Top Ranking Among Healthcare Companies in Bloomberg Gender-Equality Index
AMN Healthcare Achieves Top Ranking Among Healthcare Companies in Bloomberg Gender-Equality Index


AMN Healthcare (NYSE: AMN) is one of 380 companies across 11 industry sectors and 44 countries included in the 2021 Bloomberg Gender-Equality Index (GEI). In the healthcare sector, AMN Healthcare

Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China
Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China


January 31, 2021—Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China, a leading investment firm, today announced a

Puma Biotechnology Presents Interim Results from the Phase II SUMMIT Trial of Neratinib for EGFR Exon 18-Mutated, Metastatic Non-Small Cell Lung Cancer at WCLC 2020: https://mms.businesswire.com/media/20191106005906/en/305625/5/puma_logo_JPEG.jpg
Puma Biotechnology Presents Interim Results from the Phase II SUMMIT Trial of Neratinib for EGFR Exon 18-Mutated, Metastatic Non-Small Cell Lung Cancer at WCLC 2020


Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, presented interim results from the ongoing SUMMIT trial of neratinib in the cohort of metastatic non-small cell lung cancer

Quidel to Hold Fiscal Fourth Quarter and Full Year 2020 Financial Results Conference Call on February 18th, 2021
Quidel to Hold Fiscal Fourth Quarter and Full Year 2020 Financial Results Conference Call on February 18th, 2021


Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fiscal fourth quarter and

PerkinElmer Board Declares Quarterly Dividend: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer Board Declares Quarterly Dividend


The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock January 28, 2021. This dividend is payable on May 7, 2021 to all

QIAGEN erweitert wachsendes Portfolio von COVID-19 Testlösungen um dPCR-Plattform QIAcuity für Abwasser- und Mutationstests
QIAGEN erweitert wachsendes Portfolio von COVID-19 Testlösungen um dPCR-Plattform QIAcuity für Abwasser- und Mutationstests


QIAGEN gab heute bekannt, dass das wachsende Portfolio an COVID-19-Produkten um Kits für Abwassertests ergänzt wird. Der Einsatz der Digitalen PCR (dPCR) bei der weltweiten Überwachung von COVID-19

QIAGEN Adds dPCR Platform QIAcuity to Growing Portfolio of COVID-19 Testing Solutions for Wastewater and Mutation Testing
QIAGEN Adds dPCR Platform QIAcuity to Growing Portfolio of COVID-19 Testing Solutions for Wastewater and Mutation Testing


QIAGEN today announced the addition of kits for wastewater testing to its growing portfolio of COVID-19 products. The use of dPCR in the worldwide surveillance of COVID-19 is an additional step

NANOBIOTIX Announces First Patient Injected With NBTXR3 in Esophageal Cancer: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBIOTIX Announces First Patient Injected With NBTXR3 in Esophageal Cancer


Regulatory News:



“We believe that NBTXR3 could have a positive impact for patients with cancer in any case where radiotherapy is a part of the standard of care. Expansion into esophageal cancer

Waters Corporation Recognized for Commitment to Diversity and Inclusion by the Human Rights Campaign Foundation
Waters Corporation Recognized for Commitment to Diversity and Inclusion by the Human Rights Campaign Foundation


Waters Corporation (NYSE:WAT) today announced that it received a score of 95 out of 100 on the 2021 Corporate Equality Index (CEI), the Human Rights Campaign Foundation’s annual scorecard for LGBTQ

Hanger Announces Date of 2020 Fourth Quarter Earnings Release and Conference Call
Hanger Announces Date of 2020 Fourth Quarter Earnings Release and Conference Call


Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, today announced it will report its financial results for the fourth quarter and twelve

Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening


Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with Cypre, Inc., a biotechnology company that is using 3D hydrogel

Report: 22 Million U.S. Seniors Lack Broadband Internet Access; First Time Study Quantifies Digital Isolation of Older Americans as Pandemic Continues to Ravage Nation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Report: 22 Million U.S. Seniors Lack Broadband Internet Access; First Time Study Quantifies Digital Isolation of Older Americans as Pandemic Continues to Ravage Nation


Older Adults Technology Services, Inc. (OATS), in partnership with the Humana Foundation, today released a new report that for the first time quantifies the size and degree of the digital isolation

Go365® by Humana Announces Winners of Third Annual National Step Challenge, Resulting in 8.6 Billion Steps Taken and One Million Meals Donated to Feeding America®: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Go365® by Humana Announces Winners of Third Annual National Step Challenge, Resulting in 8.6 Billion Steps Taken and One Million Meals Donated to Feeding America®


Today, leading health and well-being company, Humana Inc. (NYSE: HUM), announced the winners of its 2020 Go365 National Step Challenge – a health and wellness contest that focuses on improving the

Waters Otto SPEcialist Positive Pressure Manifold Improves Reproducibility and Reliability of Solid-Phase Extraction (SPE)
Waters Otto SPEcialist Positive Pressure Manifold Improves Reproducibility and Reliability of Solid-Phase Extraction (SPE)


Waters Corporation (NYSE:WAT) today introduced the OttoTM SPEcialist Positive Pressure Manifold designed to improve the reliability and reproducibility of solid phase extraction (SPE). Equipped

Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® (tofacitinib) in Subjects with Rheumatoid Arthritis (RA) http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® (tofacitinib) in Subjects with Rheumatoid Arthritis (RA)


Pfizer Inc. (NYSE: PFE) announced today co-primary endpoint results from a recently completed post-marketing required safety study, ORAL Surveillance (A3921133; NCT02092467). The primary objective

Hanger Foundation Announces Scholarship to Help Promote Diversity in Orthotics and Prosthetics Graduate Programs
Hanger Foundation Announces Scholarship to Help Promote Diversity in Orthotics and Prosthetics Graduate Programs


The Hanger Foundation today announced the creation of the Hanger Foundation Diversity Scholarship as part of its commitment to diversity and inclusion in the orthotics and prosthetics (O&P)

Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation
Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation


Agilent Technologies Inc. (NYSE: A) will release first-quarter fiscal year 2021 financial results after the stock market closes on Tuesday, Feb. 16. The company will host a live webcast of its

Elizabeth Yeu, M.D. and K. Peony Yu, M.D. Appointed to STAAR Surgical Board of Directors: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
Elizabeth Yeu, M.D. and K. Peony Yu, M.D. Appointed to STAAR Surgical Board of Directors


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the appointments of Elizabeth

Partners in Primary Care Announces 2021 Growth Plans for Its Senior-Focused Care Facilities: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Partners in Primary Care Announces 2021 Growth Plans for Its Senior-Focused Care Facilities


Partners in Primary Care announced today the details of its 2021 expansion. Having opened 15 new centers in 2020, plans for 2021 include up to 20 more centers, including entering the Atlanta

Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it

Eyenovia to Present at the Ophthalmology Innovation Summit (OIS) Presbyopia Innovation Showcase
Eyenovia to Present at the Ophthalmology Innovation Summit (OIS) Presbyopia Innovation Showcase


Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced that Dr. David Wirta will

QIAGEN N.V. to Report Fourth Quarter and Full-Year 2020 Results
QIAGEN N.V. to Report Fourth Quarter and Full-Year 2020 Results


QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced today that it plans to release its report on results for the fourth quarter and full-year 2020 on Tuesday, February 9,at

Nanobiotix Subsidiary Curadigm Secures New Collaboration Agreement With Sanofi Focused on Gene Therapy Pipeline : https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix Subsidiary Curadigm Secures New Collaboration Agreement With Sanofi Focused on Gene Therapy Pipeline


NANOBIOTIX (Paris:NANO) (NASDAQ:NBTX) (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a clinical-stage biotechnology company focused on developing first-in-class product candidates that use

Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021
Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021


Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the fourth quarter and full year 2020 following the close of market on Thursday, February 11, 2021.



On the same day, at